Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
Men Aged 18 And Older May Qualify For New Investigational Medication To Treat Low Testosterone At No Cost
IRVINE, Calif., Nov. 19, 2013 /PRNewswire/ — A recent study by JAMA Internal Medicine revealed that the proportion of middle-aged American men being treated for low testosterone has more than tripled over the last decade. As men test their “T levels,” those diagnosed with low testosterone have many treatment options. One option is volunteering for a clinical research study; these studies allow men to try advanced investigational drugs while helping doctors find the medications of tomorrow. The Irvine Center for Clinical Research, a respected and renowned clinical research provider in Southern California, has announced open enrollment for a clinical research study examining an investigational medication on testosterone levels, sex drive, and energy levels in men over the age of 18.
“There are alarming statistics regarding low testosterone in men. According to the American Diabetes Association, nearly 13 million American men may be affected. More than half of men with low testosterone report erectile dysfunction and most say they have a low sex drive,” said Dr. Denny Lee, Principal Investigator, Irvine Center for Clinical Research. “We need men who are experiencing these symptoms to participate in clinical studies and volunteer to take research study medications. Only through research studies like these can doctors find safer and more effective treatments.”
Normal testosterone levels range from 300 to 1,000 nanograms per deciliter of blood, according to the U.S. National Library of Medicine. A low reading means the testicles are not producing enough testosterone. Men who have been diagnosed with low testosterone may experience symptoms such as reduced sex drive, reduced energy, reduced strength as well as sexual dysfunction, and may want to consider joining a clinical study.
Qualified participants of the clinical research study may receive 9 months’ dosage of investigational medication at no cost, as well as travel and time reimbursements of up to $400. Interested parties should contact Irvine Center for Clinical Research to learn more and schedule a no-cost screening and consultation.
To learn more about the low testosterone study being conducted at Irvine Center for Clinical Research or to see if you qualify, visit www.irvineclinical.com.
About Irvine Center for Clinical Research
Irvine Center for Clinical Research is an independent medical research clinic in Irvine, California, specializing in researching investigational medications and providing study-related care to participants at no cost. Since its original founding in 1978, Irvine Center for Clinical Research has delivered research opportunities and solutions to men and women in the greater Los Angeles area. The team at Irvine Center for Clinical Research is staffed by full-time principal investigators, clinical research coordinators, laboratory and regulatory staff, and takes pride in developing the best possible physician-patient relationship with each new study. To learn more about Irvine Center for Clinical Research, visit www.irvineclinical.com.
Claire Delacruz Soe
Soe Communications Group
SOURCE Irvine Center for Clinical Research